---
title: "hMPV Interview with Guy Boivin & hVIVO’s Chief Scientific Officer"
publisher: "Share Talk"
author: "sharetalk"
published: "2025-11-19T10:34:59+00:00"
modified: "2025-11-19T10:34:59+00:00"
date: 2025-11-19
canonical: "https://www.share-talk.com/hmpv-interview-with-guy-boivin-hvivos-chief-scientific-officer/"
category: "Exclusive Interviews"
categories: ["Exclusive Interviews", "Health", "Healthcare", "Pharmaceutical"]
tags: ["Andrew Catchpole", "antiviral", "breast cancer", "Canary Wharf", "Cathal Friel", "CHIMagents", "clinical respiratory drug", "Codagenix", "COVID-19", "Dengue Fever", "Dr Andrew Catchpole", "Dr Chris Chiu", "Gregory Stoloff", "hVIVO", "Imperial College London", "Imutex Ltd", "laboratory", "Malaria", "Open Orphan", "ORPH", "Oxford BioTherapeutics", "pharmaceutical", "quarantine clinic", "Rahim Fandi", "Share Talk", "Stephen Pinkerton", "The Lancet", "Vaccine", "virology", "West Nile Virus", "Yamin 'Mo' Khan", "Zika"]
image: "https://i0.wp.com/www.share-talk.com/wp-content/uploads/2025/11/2-hMPV-Interview-with-Guy-Boivin-hVIVOs-Chief-Scientific-Officer-You.-2025-11-19-at-10.16.00-AM.webp?fit=1200%2C597&quality=80&ssl=1"
format: "news"
language: "en-GB"
---

# hMPV Interview with Guy Boivin & hVIVO’s Chief Scientific Officer

**Published:** November 19, 2025
**Author:** sharetalk
**Categories:** Exclusive Interviews, Health, Healthcare, Pharmaceutical
**Tags:** Andrew Catchpole, antiviral, breast cancer, Canary Wharf, Cathal Friel, CHIMagents, clinical respiratory drug, Codagenix, COVID-19, Dengue Fever, Dr Andrew Catchpole, Dr Chris Chiu, Gregory Stoloff, hVIVO, Imperial College London, Imutex Ltd, laboratory, Malaria, Open Orphan, ORPH, Oxford BioTherapeutics, pharmaceutical, quarantine clinic, Rahim Fandi, Share Talk, Stephen Pinkerton, The Lancet, Vaccine, virology, West Nile Virus, Yamin 'Mo' Khan, Zika
**Featured image:** ![](https://i0.wp.com/www.share-talk.com/wp-content/uploads/2025/11/2-hMPV-Interview-with-Guy-Boivin-hVIVOs-Chief-Scientific-Officer-You.-2025-11-19-at-10.16.00-AM.webp?fit=1200%2C597&quality=80&ssl=1)

---

Join us for an insightful conversation on [hMPV](https://www.share-talk.com/hvivo-plc-diversification-in-action-as-2026-growth-beckons/) featuring our Chief Scientific Officer, Dr Andrew Catchpole and Guy Boivin, a professor from Laval University and one of the founding fathers in the discovery and ongoing research into hMPV.

hMPV’s discovery

‍ Need to find a treatment to address hMPV

The burden and severities of hMPV

Could hMPV be the next pandemic?

[hVIVO](https://www.share-talk.com/hvivo-plc-diversification-in-action-as-2026-growth-beckons/) is proud to play a small part in the hMPV story by developing the first commercially available hMPV human challenge study.

If you would like to learn more about hMPV, reach out to us directly via [bd@hvivo.com](mailto:bd@hvivo.com)

---

**Original URL:** https://www.share-talk.com/hmpv-interview-with-guy-boivin-hvivos-chief-scientific-officer/
*Created by [WP Markdown Endpoint](https://wpmarkdownendpoint.com/)*
